Loading…
Phenacetin O-deethylation by human liver microsomes in vitro : inhibition by chemical probes, SSRI antidepressants, nefazodone and venlafaxine
Biotransformation of phenacetin via O-deethylation to acetaminophen, an index reaction reflecting activity of Cytochrome P450-1A2, was studied in microsomal preparations from a series of human livers. Acetaminophen formation was consistent with a double Michaelis-Menten system, with low-Km (mean Km1...
Saved in:
Published in: | Psychopharmacologia 1996-12, Vol.128 (4), p.398-407 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c383t-852c8dfe81a01aa020cb79c9da6326b4058a46a5a8427f3160b3366643d09e7e3 |
---|---|
cites | |
container_end_page | 407 |
container_issue | 4 |
container_start_page | 398 |
container_title | Psychopharmacologia |
container_volume | 128 |
creator | VON MOLTKE, L. L GREENBLATT, D. J SU XIANG DUAN SCHMIDER, J KUDCHADKER, L FOGELMAN, S. M HARMATZ, J. S SHADER, R. I |
description | Biotransformation of phenacetin via O-deethylation to acetaminophen, an index reaction reflecting activity of Cytochrome P450-1A2, was studied in microsomal preparations from a series of human livers. Acetaminophen formation was consistent with a double Michaelis-Menten system, with low-Km (mean Km1 = 68 microM) and high-Km (mean Km2 = 7691 microM) components. The low-K(m) enzyme accounted for an average of 96% of estimated intrinsic clearance, and was predicted to contribute more than 50% of net reaction velocity at phenacetin concentrations less than 2000 microM. Among index inhibitor probes, alpha-naphthoflavone was a highly potent inhibitor of the low-Km enzyme (Ki1 = 0.013 microM); furafylline also was a moderately active inhibitor (Ki1 = 4.4 microM), but its inhibiting potency was increased by preincubation with microsomes. Ketoconazole was a relatively weak inhibitor (Ki1 = 32 microM); quinidine and cimetidine showed minimal inhibiting activity. Among six selective serotonin reuptake inhibitor (SSRI) antidepressants, fluvoxamine was a potent inhibitor of 1A2 (mean Ki1 = 0.24 microM). The other SSRIs were more than tenfold less potent. Mean Ki1 values were: fluoxetine, 4.4 microM; norfluoxetine, 15.9 microM; sertraline, 8.8 microM; desmethylsertraline, 9.5 microM; paroxetine, 5.5 microM. The antidepressant nefazodone and four of its metabolites (meta-chloro-phenylpiperazine, two hydroxylated derivatives, and a triazoledione) were very weak inhibitors of P450-1A2. Venlafaxine and its O- and N-desmethyl metabolites showed minimal inhibitory activity. |
doi_str_mv | 10.1007/s002130050149 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78641812</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78641812</sourcerecordid><originalsourceid>FETCH-LOGICAL-c383t-852c8dfe81a01aa020cb79c9da6326b4058a46a5a8427f3160b3366643d09e7e3</originalsourceid><addsrcrecordid>eNpVkE9r3DAQxUVpSLdpjz0WdCg51c3oj2U5txDSJhBIadqzGctjrGLLG8m7ZPMh-pmjkE2gc5lh3o_HzGPsk4BvAqA6SQBSKIAShK7fsJXQShYSKvmWrQCUKpQo7Tv2PqW_kEtbfcgObW0NCFixfz8HCuho8YHfFB3RMuxGXPwceLvjw2bCwEe_pcgn7-Kc5okSz-zWL3Hmp3kcfOtfeDdQxnDk6zi3lL7y29tfVxzD4jtaR0opj3kbqMeHuZsDZa3jWwoj9njvA31gBz2OiT7u-xH78_3i9_llcX3z4-r87LpwyqqlsKV0tuvJCgSBCBJcW9Wu7tAoaVoNpUVtsESrZdUrYaBVyhijVQc1VaSO2PGzbz70bkNpaSafHI0jBpo3qams0cIKmcHiGXx6PkXqm3X0E8ZdI6B5yr_5L__Mf94bb9qJuld6H3jWv-x1TDmoPmJwPr1ishRCGKkeAZgtjiU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78641812</pqid></control><display><type>article</type><title>Phenacetin O-deethylation by human liver microsomes in vitro : inhibition by chemical probes, SSRI antidepressants, nefazodone and venlafaxine</title><source>Springer Online Journals Archive Complete</source><source>EBSCOhost SPORTDiscus - Ebooks</source><creator>VON MOLTKE, L. L ; GREENBLATT, D. J ; SU XIANG DUAN ; SCHMIDER, J ; KUDCHADKER, L ; FOGELMAN, S. M ; HARMATZ, J. S ; SHADER, R. I</creator><creatorcontrib>VON MOLTKE, L. L ; GREENBLATT, D. J ; SU XIANG DUAN ; SCHMIDER, J ; KUDCHADKER, L ; FOGELMAN, S. M ; HARMATZ, J. S ; SHADER, R. I</creatorcontrib><description>Biotransformation of phenacetin via O-deethylation to acetaminophen, an index reaction reflecting activity of Cytochrome P450-1A2, was studied in microsomal preparations from a series of human livers. Acetaminophen formation was consistent with a double Michaelis-Menten system, with low-Km (mean Km1 = 68 microM) and high-Km (mean Km2 = 7691 microM) components. The low-K(m) enzyme accounted for an average of 96% of estimated intrinsic clearance, and was predicted to contribute more than 50% of net reaction velocity at phenacetin concentrations less than 2000 microM. Among index inhibitor probes, alpha-naphthoflavone was a highly potent inhibitor of the low-Km enzyme (Ki1 = 0.013 microM); furafylline also was a moderately active inhibitor (Ki1 = 4.4 microM), but its inhibiting potency was increased by preincubation with microsomes. Ketoconazole was a relatively weak inhibitor (Ki1 = 32 microM); quinidine and cimetidine showed minimal inhibiting activity. Among six selective serotonin reuptake inhibitor (SSRI) antidepressants, fluvoxamine was a potent inhibitor of 1A2 (mean Ki1 = 0.24 microM). The other SSRIs were more than tenfold less potent. Mean Ki1 values were: fluoxetine, 4.4 microM; norfluoxetine, 15.9 microM; sertraline, 8.8 microM; desmethylsertraline, 9.5 microM; paroxetine, 5.5 microM. The antidepressant nefazodone and four of its metabolites (meta-chloro-phenylpiperazine, two hydroxylated derivatives, and a triazoledione) were very weak inhibitors of P450-1A2. Venlafaxine and its O- and N-desmethyl metabolites showed minimal inhibitory activity.</description><identifier>ISSN: 0033-3158</identifier><identifier>EISSN: 1432-2072</identifier><identifier>DOI: 10.1007/s002130050149</identifier><identifier>PMID: 8986010</identifier><identifier>CODEN: PSYPAG</identifier><language>eng</language><publisher>Berlin: Springer</publisher><subject>Antidepressive Agents, Second-Generation - pharmacology ; Biological and medical sciences ; Biotransformation - drug effects ; Cyclohexanols - pharmacology ; Cytochrome P-450 CYP1A1 - metabolism ; Cytochrome P-450 CYP1A2 - metabolism ; Cytochrome P-450 Enzyme Inhibitors ; Cytochrome P-450 Enzyme System - metabolism ; Enzyme Inhibitors - pharmacology ; Humans ; Medical sciences ; Microsomes, Liver - drug effects ; Microsomes, Liver - metabolism ; Neuropharmacology ; Pharmacology. Drug treatments ; Phenacetin - metabolism ; Piperazines ; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) ; Psychology. Psychoanalysis. Psychiatry ; Psychopharmacology ; Serotonin Uptake Inhibitors - pharmacology ; Triazoles - pharmacology ; Venlafaxine Hydrochloride</subject><ispartof>Psychopharmacologia, 1996-12, Vol.128 (4), p.398-407</ispartof><rights>1997 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c383t-852c8dfe81a01aa020cb79c9da6326b4058a46a5a8427f3160b3366643d09e7e3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2511162$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8986010$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>VON MOLTKE, L. L</creatorcontrib><creatorcontrib>GREENBLATT, D. J</creatorcontrib><creatorcontrib>SU XIANG DUAN</creatorcontrib><creatorcontrib>SCHMIDER, J</creatorcontrib><creatorcontrib>KUDCHADKER, L</creatorcontrib><creatorcontrib>FOGELMAN, S. M</creatorcontrib><creatorcontrib>HARMATZ, J. S</creatorcontrib><creatorcontrib>SHADER, R. I</creatorcontrib><title>Phenacetin O-deethylation by human liver microsomes in vitro : inhibition by chemical probes, SSRI antidepressants, nefazodone and venlafaxine</title><title>Psychopharmacologia</title><addtitle>Psychopharmacology (Berl)</addtitle><description>Biotransformation of phenacetin via O-deethylation to acetaminophen, an index reaction reflecting activity of Cytochrome P450-1A2, was studied in microsomal preparations from a series of human livers. Acetaminophen formation was consistent with a double Michaelis-Menten system, with low-Km (mean Km1 = 68 microM) and high-Km (mean Km2 = 7691 microM) components. The low-K(m) enzyme accounted for an average of 96% of estimated intrinsic clearance, and was predicted to contribute more than 50% of net reaction velocity at phenacetin concentrations less than 2000 microM. Among index inhibitor probes, alpha-naphthoflavone was a highly potent inhibitor of the low-Km enzyme (Ki1 = 0.013 microM); furafylline also was a moderately active inhibitor (Ki1 = 4.4 microM), but its inhibiting potency was increased by preincubation with microsomes. Ketoconazole was a relatively weak inhibitor (Ki1 = 32 microM); quinidine and cimetidine showed minimal inhibiting activity. Among six selective serotonin reuptake inhibitor (SSRI) antidepressants, fluvoxamine was a potent inhibitor of 1A2 (mean Ki1 = 0.24 microM). The other SSRIs were more than tenfold less potent. Mean Ki1 values were: fluoxetine, 4.4 microM; norfluoxetine, 15.9 microM; sertraline, 8.8 microM; desmethylsertraline, 9.5 microM; paroxetine, 5.5 microM. The antidepressant nefazodone and four of its metabolites (meta-chloro-phenylpiperazine, two hydroxylated derivatives, and a triazoledione) were very weak inhibitors of P450-1A2. Venlafaxine and its O- and N-desmethyl metabolites showed minimal inhibitory activity.</description><subject>Antidepressive Agents, Second-Generation - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Biotransformation - drug effects</subject><subject>Cyclohexanols - pharmacology</subject><subject>Cytochrome P-450 CYP1A1 - metabolism</subject><subject>Cytochrome P-450 CYP1A2 - metabolism</subject><subject>Cytochrome P-450 Enzyme Inhibitors</subject><subject>Cytochrome P-450 Enzyme System - metabolism</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Microsomes, Liver - drug effects</subject><subject>Microsomes, Liver - metabolism</subject><subject>Neuropharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Phenacetin - metabolism</subject><subject>Piperazines</subject><subject>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopharmacology</subject><subject>Serotonin Uptake Inhibitors - pharmacology</subject><subject>Triazoles - pharmacology</subject><subject>Venlafaxine Hydrochloride</subject><issn>0033-3158</issn><issn>1432-2072</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><recordid>eNpVkE9r3DAQxUVpSLdpjz0WdCg51c3oj2U5txDSJhBIadqzGctjrGLLG8m7ZPMh-pmjkE2gc5lh3o_HzGPsk4BvAqA6SQBSKIAShK7fsJXQShYSKvmWrQCUKpQo7Tv2PqW_kEtbfcgObW0NCFixfz8HCuho8YHfFB3RMuxGXPwceLvjw2bCwEe_pcgn7-Kc5okSz-zWL3Hmp3kcfOtfeDdQxnDk6zi3lL7y29tfVxzD4jtaR0opj3kbqMeHuZsDZa3jWwoj9njvA31gBz2OiT7u-xH78_3i9_llcX3z4-r87LpwyqqlsKV0tuvJCgSBCBJcW9Wu7tAoaVoNpUVtsESrZdUrYaBVyhijVQc1VaSO2PGzbz70bkNpaSafHI0jBpo3qams0cIKmcHiGXx6PkXqm3X0E8ZdI6B5yr_5L__Mf94bb9qJuld6H3jWv-x1TDmoPmJwPr1ishRCGKkeAZgtjiU</recordid><startdate>19961201</startdate><enddate>19961201</enddate><creator>VON MOLTKE, L. L</creator><creator>GREENBLATT, D. J</creator><creator>SU XIANG DUAN</creator><creator>SCHMIDER, J</creator><creator>KUDCHADKER, L</creator><creator>FOGELMAN, S. M</creator><creator>HARMATZ, J. S</creator><creator>SHADER, R. I</creator><general>Springer</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19961201</creationdate><title>Phenacetin O-deethylation by human liver microsomes in vitro : inhibition by chemical probes, SSRI antidepressants, nefazodone and venlafaxine</title><author>VON MOLTKE, L. L ; GREENBLATT, D. J ; SU XIANG DUAN ; SCHMIDER, J ; KUDCHADKER, L ; FOGELMAN, S. M ; HARMATZ, J. S ; SHADER, R. I</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c383t-852c8dfe81a01aa020cb79c9da6326b4058a46a5a8427f3160b3366643d09e7e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Antidepressive Agents, Second-Generation - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Biotransformation - drug effects</topic><topic>Cyclohexanols - pharmacology</topic><topic>Cytochrome P-450 CYP1A1 - metabolism</topic><topic>Cytochrome P-450 CYP1A2 - metabolism</topic><topic>Cytochrome P-450 Enzyme Inhibitors</topic><topic>Cytochrome P-450 Enzyme System - metabolism</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Microsomes, Liver - drug effects</topic><topic>Microsomes, Liver - metabolism</topic><topic>Neuropharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Phenacetin - metabolism</topic><topic>Piperazines</topic><topic>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopharmacology</topic><topic>Serotonin Uptake Inhibitors - pharmacology</topic><topic>Triazoles - pharmacology</topic><topic>Venlafaxine Hydrochloride</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>VON MOLTKE, L. L</creatorcontrib><creatorcontrib>GREENBLATT, D. J</creatorcontrib><creatorcontrib>SU XIANG DUAN</creatorcontrib><creatorcontrib>SCHMIDER, J</creatorcontrib><creatorcontrib>KUDCHADKER, L</creatorcontrib><creatorcontrib>FOGELMAN, S. M</creatorcontrib><creatorcontrib>HARMATZ, J. S</creatorcontrib><creatorcontrib>SHADER, R. I</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Psychopharmacologia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>VON MOLTKE, L. L</au><au>GREENBLATT, D. J</au><au>SU XIANG DUAN</au><au>SCHMIDER, J</au><au>KUDCHADKER, L</au><au>FOGELMAN, S. M</au><au>HARMATZ, J. S</au><au>SHADER, R. I</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Phenacetin O-deethylation by human liver microsomes in vitro : inhibition by chemical probes, SSRI antidepressants, nefazodone and venlafaxine</atitle><jtitle>Psychopharmacologia</jtitle><addtitle>Psychopharmacology (Berl)</addtitle><date>1996-12-01</date><risdate>1996</risdate><volume>128</volume><issue>4</issue><spage>398</spage><epage>407</epage><pages>398-407</pages><issn>0033-3158</issn><eissn>1432-2072</eissn><coden>PSYPAG</coden><abstract>Biotransformation of phenacetin via O-deethylation to acetaminophen, an index reaction reflecting activity of Cytochrome P450-1A2, was studied in microsomal preparations from a series of human livers. Acetaminophen formation was consistent with a double Michaelis-Menten system, with low-Km (mean Km1 = 68 microM) and high-Km (mean Km2 = 7691 microM) components. The low-K(m) enzyme accounted for an average of 96% of estimated intrinsic clearance, and was predicted to contribute more than 50% of net reaction velocity at phenacetin concentrations less than 2000 microM. Among index inhibitor probes, alpha-naphthoflavone was a highly potent inhibitor of the low-Km enzyme (Ki1 = 0.013 microM); furafylline also was a moderately active inhibitor (Ki1 = 4.4 microM), but its inhibiting potency was increased by preincubation with microsomes. Ketoconazole was a relatively weak inhibitor (Ki1 = 32 microM); quinidine and cimetidine showed minimal inhibiting activity. Among six selective serotonin reuptake inhibitor (SSRI) antidepressants, fluvoxamine was a potent inhibitor of 1A2 (mean Ki1 = 0.24 microM). The other SSRIs were more than tenfold less potent. Mean Ki1 values were: fluoxetine, 4.4 microM; norfluoxetine, 15.9 microM; sertraline, 8.8 microM; desmethylsertraline, 9.5 microM; paroxetine, 5.5 microM. The antidepressant nefazodone and four of its metabolites (meta-chloro-phenylpiperazine, two hydroxylated derivatives, and a triazoledione) were very weak inhibitors of P450-1A2. Venlafaxine and its O- and N-desmethyl metabolites showed minimal inhibitory activity.</abstract><cop>Berlin</cop><pub>Springer</pub><pmid>8986010</pmid><doi>10.1007/s002130050149</doi><tpages>10</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0033-3158 |
ispartof | Psychopharmacologia, 1996-12, Vol.128 (4), p.398-407 |
issn | 0033-3158 1432-2072 |
language | eng |
recordid | cdi_proquest_miscellaneous_78641812 |
source | Springer Online Journals Archive Complete; EBSCOhost SPORTDiscus - Ebooks |
subjects | Antidepressive Agents, Second-Generation - pharmacology Biological and medical sciences Biotransformation - drug effects Cyclohexanols - pharmacology Cytochrome P-450 CYP1A1 - metabolism Cytochrome P-450 CYP1A2 - metabolism Cytochrome P-450 Enzyme Inhibitors Cytochrome P-450 Enzyme System - metabolism Enzyme Inhibitors - pharmacology Humans Medical sciences Microsomes, Liver - drug effects Microsomes, Liver - metabolism Neuropharmacology Pharmacology. Drug treatments Phenacetin - metabolism Piperazines Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) Psychology. Psychoanalysis. Psychiatry Psychopharmacology Serotonin Uptake Inhibitors - pharmacology Triazoles - pharmacology Venlafaxine Hydrochloride |
title | Phenacetin O-deethylation by human liver microsomes in vitro : inhibition by chemical probes, SSRI antidepressants, nefazodone and venlafaxine |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T00%3A14%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Phenacetin%20O-deethylation%20by%20human%20liver%20microsomes%20in%20vitro%20:%20inhibition%20by%20chemical%20probes,%20SSRI%20antidepressants,%20nefazodone%20and%20venlafaxine&rft.jtitle=Psychopharmacologia&rft.au=VON%20MOLTKE,%20L.%20L&rft.date=1996-12-01&rft.volume=128&rft.issue=4&rft.spage=398&rft.epage=407&rft.pages=398-407&rft.issn=0033-3158&rft.eissn=1432-2072&rft.coden=PSYPAG&rft_id=info:doi/10.1007/s002130050149&rft_dat=%3Cproquest_cross%3E78641812%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c383t-852c8dfe81a01aa020cb79c9da6326b4058a46a5a8427f3160b3366643d09e7e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=78641812&rft_id=info:pmid/8986010&rfr_iscdi=true |